Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TARGET FOR CHRONIC PAIN TREATMENT AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/142230
Kind Code:
A1
Abstract:
Provided is a target for chronic pain treatment, ALKBH5. It is found that ALKBH5 is specifically and differentially overexpressed in pain models, and the reduced expression of ALKBH5 can significantly relieve chronic pains, indicating that ALKBH5 plays an important role in the development and progression of chronic pains and thus provides a new possibility for medication development, prevention, and treatment of chronic pains.

Inventors:
TAO JIN (CN)
HUANG ZITONG (CN)
ZHANG YUAN (CN)
Application Number:
PCT/CN2022/079769
Publication Date:
August 03, 2023
Filing Date:
March 08, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV SOOCHOW (CN)
International Classes:
A61K31/713; C12Q1/6883; A61P25/02; A61P25/06; A61P29/00; A61P35/00; C12Q1/6886
Domestic Patent References:
WO2020207550A12020-10-15
Foreign References:
CN110420331A2019-11-08
CN112716971A2021-04-30
CN110055284A2019-07-26
Other References:
SUN, ZELONG: "Study on the Mechanism of ALKBH5 Inhibiting TGF-β induced Epithelial-mesenchymal Transition in Non-small Cell Lung Cancer Cells", CHINA MASTER’S THESES FULL-TEXT DATABASE, MEDICINE AND HEALTH SCIENCES, no. 02, 15 February 2021 (2021-02-15)
ZHANG, SICONG ET AL.: "m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.", CANCER CELL, vol. 31, 23 March 2017 (2017-03-23), XP029974958, DOI: 10.1016/j.ccell.2017.02.013
ALBIK, S. ET AL.: "Emerging Role of RNA m6A Modification in Chronic Pain", PAIN, vol. 162, no. 7, 1 July 2021 (2021-07-01), XP009548374
Attorney, Agent or Firm:
CENTRAL SOUTH WELL INTELLECTUAL PROPERTY OFFICE (CN)
Download PDF: